ATG5 and asthma: Multiple lines of evidence have demonstrated that several ATG5 polymorphisms influence patient predisposition to various inflammatory diseases, including asthma, SLE and Parkinson’s disease, by altering ATG5 expression levels and autophagy activity26–28.